In this context, James Carson et al. (Center for Colon Cancer Research University of South Carolina) showed that mammalian target of rapamycin (mTOR) signalling is activated after the dark cycle in wild‐type mice and associated with the activation of protein synthesis but can be disassociated from protein synthesis in tumour bearing mice. This evidence concerns the gene MTOR and neoplasm.